Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer.
- Author:
Gang LI
1
;
Rong-min GU
;
Xu WEN
;
Xue-zhi MING
;
Lei XIA
;
Xin-yu XU
;
Ji ZHANG
;
Huan-qiu CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Aged, 80 and over; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Prognosis; Receptor, Epidermal Growth Factor; metabolism; Receptor, ErbB-2; metabolism; Receptor, ErbB-3; metabolism; Receptor, ErbB-4; Retrospective Studies; Stomach Neoplasms; metabolism; pathology
- From: Chinese Journal of Gastrointestinal Surgery 2013;16(7):668-672
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the association of human epidermal growth factor receptor family molecules expression in gastric cancer tissues with the prognosis of patients with gastric cancer.
METHODSClinical data of 161 patients with gastric cancer undergoing gastrectomy in Jiangsu Cancer Hospital between January 2006 and January 2007 were analyzed retrospectively. The expression of HER1, HER2, HER3 and HER4 was detected by immunohistochemistry. Association of the expression of HER family with the prognosis of patients was examined. Kaplan-Meier method was used to analyze the survival.
RESULTSHigh expression rates of HER1, HER2, HER3 and HER4 were 46.0% (74/161), 10.6% (17/161),55.9% (90/161) and 68.3% (110/161) respectively. Univariate analysis revealed that high expression of HER3 was associated with tumor invasion depth, lymph node metastasis, stage, neurovascular invasion, and overall 4-year survival. High expression of HER4 was associated with tumor distant metastasis and stage. High co-expression of HER2 and HER3 was associated with overall 4-year survival (P=0.023). Multivariate analysis revealed that high expression of HER3 and stage were prognostic independent factors.
CONCLUSIONUp-regulated expression of HER3 is associated with the poor prognosis in gastric cancer patients.
